A comparison of pethidine/meperidine intramusculary and remifentanil patient-controlled analgesia during labor in Westfriesgasthuis

Phase 3

Completed

• Conditions: contraction-pain; pain during labour; 10010273

• Registration Number: NL-OMON30677
• Lead Sponsor: Westfries Gasthuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 274

Inclusion Criteria

Pregnant and ASA1, women in labor in Westfries gasthuis, planned vaginal delivery, informed consent parturient, a term pregnancy (37+0 till 42+0 weeks), unborn lies in head-down-position, the unborn has no congenital abnormalities

Exclusion Criteria

Pregnant woman requesting epidural analgesia or undergoing epidural analgesia, pregnancy is not a term (<37+0 or >42+0 weeks), kwown allergie for remifentanil, paturient who feels she does not have right amount of time to consider enrolling in this study, other fetal positions than head down, fetal congenital abnormalities

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Patient satisfaction</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Safety for mother and child including: maternal saturation, respiratory rate<br /><br>and bloodpressure, neonatal Apgar scores and saturation.<br /><br>Painrelief, measured by maternal VAS-scores.</p><br>